• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Arcturus Therapeutics

    Arcturus Therapeutics Receives Clearance of an Investigational New Drug Application to U.S. Food and Drug Administration for ARCT-032, an Investigational Inhaled mRNA Therapeutic to Treat Cystic Fibrosis
    From Arcturus Therapeutics
    Via Business Wire
    Tickers ARCT
    Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics’ COVID-19 Vaccine
    From Arcturus Therapeutics
    Via Business Wire
    Tickers ARCT ASX:CSL CSLLY OTC
    New COVID-19 sa-mRNA Results from CSL and Arcturus Therapeutics Demonstrate Longer Duration of Immunity Compared to Conventional COVID-19 mRNA Vaccine Booster
    From Arcturus Therapeutics
    Via Business Wire
    Tickers ARCT ASX:CSL CSLLY OTC
    CSL and Arcturus Therapeutics’ ARCT-154 Demonstrates Non-Inferiority to Original Strain and Superior Immunogenicity to Omicron BA.4/5 Variant Compared to First-Generation mRNA Vaccine Booster
    From Arcturus Therapeutics
    Via Business Wire
    Tickers ARCT ASX:CSL CSLLY OTC
    Arcturus Therapeutics to Attend Upcoming Investor Conferences
    From Arcturus Therapeutics
    Via Business Wire
    Tickers ARCT
    Arcturus Therapeutics Joint Venture mRNA Manufacturing Partner, ARCALIS, Awarded $115 Million in Grants from the Japanese Government
    From Arcturus Therapeutics
    Via Business Wire
    Tickers ARCT
    Arcturus Therapeutics to Report First Quarter 2022 Financial Results and Provide Corporate Update on May 9, 2022
    From Arcturus Therapeutics
    Via Business Wire
    Tickers ARCT
    Arcturus Therapeutics to Report Fourth Quarter and Year-End 2021 Financial Results and Provide Corporate Update on February 28, 2022
    From Arcturus Therapeutics
    Via Business Wire
    Tickers ARCT
    Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
    From Arcturus Therapeutics
    Via Business Wire
    Tickers ARCT
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.